-
81
Challenges faced during antitubercular therapy
Published 2024-07-01“…The patient presented with peripheral neuropathy, deranged liver function, elevated uric acid levels, gastritis, and psychological distress during the treatment period. …”
Get full text
Article -
82
Relapsing Hepatitis A Infection with Immunological Sequelae
Published 1989-01-01“…A patient with persistent anti-hepatitis A virus (HAV) lgM following icteric hepatitis A, vasculitis, arthritis and peripheral neuropathy is reported. The clinical, biochemical and serological features of re lapsing hepatitis A arc described.…”
Get full text
Article -
83
Yersiniosis and acute secondary axonal sensorimotor polyneuropathy: a case report
Published 2019-03-01“…There were no other causes of peripheral neuropathy detected and we assume that yersiniosis was the cause of acute axonal sensorimotor polyneuropathylanguage most frequently inhibited EDs in patients with focal epilepsy and reading in an unknown language had the same effect on patients with generalized epilepsy. …”
Get full text
Article -
84
The Need for Improved Management of Painful Diabetic Neuropathy in Primary Care
Published 2016-01-01“…The provision of care for patients with type II diabetes in primary care must involve assessing patients for peripheral neuropathy of the feet. Objectives. This paper will demonstrate that painful diabetic neuropathy (PDN) is poorly assessed for and treated in primary care. …”
Get full text
Article -
85
Atypical Presentation of Kimura’s Disease in a Male Patient: A Case Report and Review of Literature
Published 2022-01-01“…Here, we report the second documented case of KD in Palestine diagnosed in a 28-year-old male patient who presented with lymphadenopathy and increased serum immunoglobulin E and G (IgE and IgG) associated with intermittent abdominal pain, generalised fatigue, hepatomegaly, cardiomyopathy, reactive airway disease, peripheral vasculopathy, peripheral neuropathy, and focal segmental glomerulosclerosis. …”
Get full text
Article -
86
Sensory-Motor Polyneuropathy and Digital Ischemia: A Rare Presentation of Granulomatosis with Polyangiitis
Published 2021-01-01“…This case highlights the importance of suspecting GPA in a patient presenting with sensorimotor polyneuropathy and/or digital ischemia even in the absence of more classic presenting features and underlies the necessity of accurate differential diagnosis in evaluating a case of peripheral neuropathy.…”
Get full text
Article -
87
A Presentation of Cerebritis Secondary to Granulomatosis with Polyangiitis (Wegener)
Published 2014-01-01“…Neurological manifestations of GPA are common, most frequently as a peripheral neuropathy. Cerebritis as a principal presentation is extremely rare. …”
Get full text
Article -
88
Isolation of Intact Mitochondria From Drosophila melanogaster and Assessment of Mitochondrial Respiratory Capacity Using Seahorse Analyzer
Published 2025-02-01“…Neurodegenerative disorders such as chemotherapy-induced peripheral neuropathy (CIPN) often exhibit damaged mitochondria or reduced mitochondrial respiratory capacity. …”
Get full text
Article -
89
Vitamin B12 Deficiency due to Chlorofluorocarbon: A Case Report
Published 2010-01-01“…Deficiency of vitamin B12 clinically manifests as excessive daytime fatigue, memory difficulties, encephalopathy, myelopathy, peripheral neuropathy, and optic neuropathy. In occupational medicine, vitamin B12 deficiency has been reported with exposure to nitrous oxide in health care workers. …”
Get full text
Article -
90
Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
Published 2012-01-01“…Mixed cyoglobulinemia is a systemic vasculitis primarily mediated by immune complexes; it is characterized by variable organ involvement including skin lesions, chronic hepatitis, glomerulonephritis, peripheral neuropathy, and arthralgias. The most frequent HCV-associated nephropathy is type I membranoproliferative glomerulonephritis, usually in the context of type II mixed cryoglobulinemia. …”
Get full text
Article -
91
Brain magnetic resonance imaging findings in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A case-based review
Published 2025-03-01“…Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare autosomal recessive disorder, manifesting with gastrointestinal dysmotility, cachexia, ptosis and peripheral neuropathy. Diffuse leukoencephalopathy in brain MRI is a hallmark of MNGIE. …”
Get full text
Article -
92
BMI, HOMA-IR, and Fasting Blood Glucose Are Significant Predictors of Peripheral Nerve Dysfunction in Adult Overweight and Obese Nondiabetic Nepalese Individuals: A Study from Cent...
Published 2016-01-01“…In this cross-sectional study, we included 50 adult overweight and obese nondiabetic volunteers without features of peripheral neuropathy and 50 healthy volunteers to determine the normative nerve conduction data. …”
Get full text
Article -
93
Muscarinic acetylcholine type 1 receptor antagonism activates TRPM3 to augment mitochondrial function and drive axonal repair in adult sensory neurons
Published 2025-02-01“…Objective: Antagonism of the muscarinic acetylcholine type 1 receptor (M1R) promotes sensory axon repair and is protective in peripheral neuropathy, however, the mechanism remains elusive. …”
Get full text
Article -
94
Administration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes Mellitus
Published 2016-01-01“…Here, we reviewed the scientific evidence underpinning the use of blood circulation activating drugs to prevent and treat DM-induced microvascular complications, including diabetic nephropathy (DN), diabetic peripheral neuropathy (DPN), and diabetic retinopathy (DR). …”
Get full text
Article -
95
P-ANCA Systemic Vasculitis Induced by Brucellosis in an Elderly Male Patient
Published 2021-01-01“…All symptoms improved from the third month of follow-up except weakness from peripheral neuropathy with normalization of P-ANCA titer. …”
Get full text
Article -
96
Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus
Published 2024-04-01“…Abstract Type 2 diabetes mellitus (T2DM) is known to be associated with macrovascular (coronary heart disease, stroke, and peripheral arterial disease) and microvascular complications (diabetic kidney disease, retinopathy, and peripheral neuropathy). The coexistence of T2DM with established/risk of atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), or chronic kidney disease confers a poor prognosis, and management can be challenging. …”
Get full text
Article -
97
Syringomyelia with Chiari I Malformation Presenting as Hip Charcot Arthropathy: A Case Report and Literature Review
Published 2015-01-01“…It is seen most commonly in the foot and ankle secondary to peripheral neuropathy associated with diabetes mellitus. …”
Get full text
Article -
98
Effects of Microtubule Stabilization by Epothilone B Depend on the Type and Age of Neurons
Published 2016-01-01“…Paradoxically, administration of MSAs, which have been widely prescribed to treat malignancies, is well known to cause debilitating peripheral neuropathy and axon degeneration. Despite the growing interest of applying MSAs to treat the injured or degenerating central nervous system (CNS), consequences of MSA exposure to neurons in the central and peripheral nervous system (PNS) have not been thoroughly investigated. …”
Get full text
Article -
99
Neuromuscular Taping in Diabetes Mellitus: A Narrative Review of Current Understanding and Potential Therapeutic Applications
Published 2024-04-01“…Abstract Background: Diabetes Mellitus (DM) poses significant challenges, including peripheral neuropathy and impaired muscle function. Neuromuscular taping has emerged as a noninvasive therapeutic approach, potentially offering benefits in managing DM-related complications. …”
Get full text
Article -
100
Major Organic Involvement in Women with Fabry Disease in Argentina
Published 2018-01-01“…And also, cornea verticillata (56.5%), peripheral neuropathy (51.4%), cardiovascular manifestations (31.4%), hearing loss (20%), angiokeratomas (20%), central nervous system (17.1%), and gastrointestinal involvement (14.3%). …”
Get full text
Article